Global Premenstrual Syndrome Treatment Market Strategic Research Report
By Type: Medication, Dietary Treatment, Emotional Treatment, Hormone Therapy, Others
By Application: Younger than 20 Years, 20-40 Years Old Adults
Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America
Key Players: AbbVie, AstraZeneca, BASF Corporation, Bayer, Eli Lilly And Company, GlaxoSmithKline, Pfizer, Shionogi, Johnson & Johnson, Novartis AG, Merck & Co., Inc., Allergan plc, Mylan N.V.
Vista general
Scope of the Report
The global Premenstrual Syndrome Treatment market size is predicted to grow from US$ 1,413 million in 2025 to US$ 1,793 million in 2032; it is expected to grow at a CAGR of 3.5% from 2026 to 2032.
Premenstrual syndrome or PMS is a group of physical and emotional symptoms many women may have in the days before their period starts. Symptoms usually stop once the period starts. It’s thought to be related to the changing hormone levels of the menstrual cycle.Lifestyle changes and sometimes medicine are used to treat PMS.
The global premenstrual syndrome (PMS) treatment market refers to the market for various products and therapies aimed at managing the symptoms associated with PMS. PMS refers to a combination of physical, emotional, and behavioral symptoms experienced by women in the days leading up to their menstrual period.
The market for PMS treatment is influenced by the growing awareness and recognition of PMS as a medical condition, the increasing number of women seeking medical assistance for PMS symptoms, and the development of new treatment options. Here are some key factors and trends in the global PMS treatment market:
Product Types: The PMS treatment market offers a range of products, including medications such as nonsteroidal anti-inflammatory drugs (NSAIDs), hormonal contraceptives, antidepressants, and diuretics. Alternative therapies like herbal remedies, nutritional supplements, and lifestyle modifications are also popular.
Hormonal Contraceptives: Hormonal contraceptives, such as oral contraceptives and intrauterine devices (IUDs), are commonly prescribed for managing PMS symptoms. These contraceptives help regulate hormone levels and reduce symptoms like mood swings, pain, and bloating.
Antidepressants: Certain antidepressant medications, particularly selective serotonin reuptake inhibitors (SSRIs), are often prescribed to alleviate the emotional symptoms associated with PMS, including irritability, depression, and anxiety.
Herbal Remedies and Nutritional Supplements: There is a growing demand for natural and holistic approaches to managing PMS symptoms. Herbal remedies like chasteberry, evening primrose oil, and black cohosh, as well as nutritional supplements like calcium, magnesium, and vitamin B6, are commonly used for symptom relief.
Awareness and Education: Increasing efforts to raise awareness about PMS and its impact on women’s health are leading to improved recognition and diagnosis of the condition. This awareness is driving the demand for effective treatment options and encouraging more women to seek medical help.
Online Platforms and Apps: The availability of online platforms and mobile applications focused on women’s health is helping to educate and empower women in managing their PMS symptoms. These platforms provide information, symptom tracking tools, and community support.
Research and Development: The PMS treatment market is witnessing ongoing research and development activities to explore new treatment options, including innovative drug therapies, herbal formulations, and personalized medicine approaches.
Regional Market: The PMS treatment market varies across regions due to differences in healthcare infrastructure, cultural beliefs, and access to medical services. North America and Europe are expected to dominate the global market due to higher awareness and healthcare expenditure, while Asia Pacific is projected to exhibit significant growth due to rising healthcare awareness and improving access to healthcare.The global premenstrual syndrome (PMS) treatment market refers to the market for various products and therapies aimed at managing the symptoms associated with PMS. PMS refers to a combination of physical, emotional, and behavioral symptoms experienced by women in the days leading up to their menstrual period.
The market for PMS treatment is influenced by the growing awareness and recognition of PMS as a medical condition, the increasing number of women seeking medical assistance for PMS symptoms, and the development of new treatment options. Here are some key factors and trends in the global PMS treatment market:
Product Types: The PMS treatment market offers a range of products, including medications such as nonsteroidal anti-inflammatory drugs (NSAIDs), hormonal contraceptives, antidepressants, and diuretics. Alternative therapies like herbal remedies, nutritional supplements, and lifestyle modifications are also popular.
Hormonal Contraceptives: Hormonal contraceptives, such as oral contraceptives and intrauterine devices (IUDs), are commonly prescribed for managing PMS symptoms. These contraceptives help regulate hormone levels and reduce symptoms like mood swings, pain, and bloating.
Antidepressants: Certain antidepressant medications, particularly selective serotonin reuptake inhibitors (SSRIs), are often prescribed to alleviate the emotional symptoms associated with PMS, including irritability, depression, and anxiety.
Herbal Remedies and Nutritional Supplements: There is a growing demand for natural and holistic approaches to managing PMS symptoms. Herbal remedies like chasteberry, evening primrose oil, and black cohosh, as well as nutritional supplements like calcium, magnesium, and vitamin B6, are commonly used for symptom relief.
Awareness and Education: Increasing efforts to raise awareness about PMS and its impact on women’s health are leading to improved recognition and diagnosis of the condition. This awareness is driving the demand for effective treatment options and encouraging more women to seek medical help.
Online Platforms and Apps: The availability of online platforms and mobile applications focused on women’s health is helping to educate and empower women in managing their PMS symptoms. These platforms provide information, symptom tracking tools, and community support.
Research and Development: The PMS treatment market is witnessing ongoing research and development activities to explore new treatment options, including innovative drug therapies, herbal formulations, and personalized medicine approaches.
Regional Market: The PMS treatment market varies across regions due to differences in healthcare infrastructure, cultural beliefs, and access to medical services. North America and Europe are expected to dominate the global market due to higher awareness and healthcare expenditure, while Asia Pacific is projected to exhibit significant growth due to rising healthcare awareness and improving access to healthcare.
This report presents a comprehensive overview of the global Premenstrual Syndrome Treatment market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.
Segment by Type
- Medication
- Dietary Treatment
- Emotional Treatment
- Hormone Therapy
- Others
Segment by Application
- Younger than 20 Years
- 20-40 Years Old Adults
Who Can Use This Report?
This report is written for decision-makers who need a clear, data-backed view of the global Premenstrual Syndrome Treatment market:
- Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
- Distributors, channel partners and end users in Younger than 20 Years, 20-40 Years Old Adults evaluating demand and sourcing options
- Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
- Government agencies, industry associations and research institutions tracking industry developments and policy impact
Market snapshot
Global Premenstrual Syndrome Treatment Market Strategic Research Report snapshot, 2025–2032
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.Segments covered in this report
Table of contents
01Executive Summary
02Industry Overview & Forecast
- 2.1.1 Market Definition and Scope
- 2.1.2 Market Size and Growth Forecast
- 2.1.3 Volume Analysis
- 2.1.4 Segment Outlook by Type
- 2.1.5 Segment Outlook by Application
- 2.1.6 Regional Outlook
- 2.1.7 Structural Developments Shaping the Forecast
- 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
- 3.1 Market Segmentation by Type
- 3.1.1 Market by Type Overview
- 3.1.2 Medication
- 3.1.3 Dietary Treatment
- 3.1.4 Emotional Treatment
- 3.1.5 Hormone Therapy
- 3.1.6 Others
- 3.1.7 Volume Analysis
04Market Segmentation by Application
- 4.1 Market Segmentation by Application
- 4.1.1 Market by Application Overview
- 4.1.2 Younger than 20 Years
- 4.1.3 20-40 Years Old Adults
- 4.1.4 Volume Analysis
05Regional Market Forecast
- Asia Pacific
- North America
- Europe
- Middle East & Africa
- Latin America
06Country-Level Market Forecast
- 6.1 Asia Pacific
- 6.1.1 China
- 6.1.2 Japan
- 6.1.3 Korea
- 6.1.4 Southeast Asia
- 6.1.5 India
- 6.1.6 Australia
- 6.1.7 Rest of Asia Pacific
- 6.2 North America
- 6.2.1 United States
- 6.2.2 Canada
- 6.2.3 Mexico
- 6.2.4 Rest of North America
- 6.3 Europe
- 6.3.1 Germany
- 6.3.2 France
- 6.3.3 UK
- 6.3.4 Italy
- 6.3.5 Russia
- 6.3.6 Rest of Europe
- 6.4 Middle East & Africa
- 6.4.1 Egypt
- 6.4.2 South Africa
- 6.4.3 Israel
- 6.4.4 Turkey
- 6.4.5 GCC Countries
- 6.4.6 Rest of Middle East & Africa
- 6.5 Latin America
- 6.5.1 Brazil
- 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
- 7.1 Growth Drivers & Inhibitors
- 7.1.1 Section Overview
- 7.1.2 Growth Drivers
- 7.1.3 Growth Inhibitors
- 7.1.4 Driver and Inhibitor Impact Assessment
- 7.1.5 Analyst Perspective
08Key Company Profiles
- 8.1 AbbVie
- 8.1.1 Company Overview
- 8.1.2 Key Products & Segments
- 8.1.3 Financial Performance (2023–2025)
- 8.1.4 Business Strategy
- 8.1.5 SWOT Analysis
- 8.1.6 Strategic Implications (2026–2032)
- 8.2 AstraZeneca
- 8.2.1 Company Overview
- 8.2.2 Key Products & Segments
- 8.2.3 Financial Performance (2023–2025)
- 8.2.4 Business Strategy
- 8.2.5 SWOT Analysis
- 8.2.6 Strategic Implications (2026–2032)
- 8.3 BASF Corporation
- 8.3.1 Company Overview
- 8.3.2 Key Products & Segments
- 8.3.3 Financial Performance (2023–2025)
- 8.3.4 Business Strategy
- 8.3.5 SWOT Analysis
- 8.3.6 Strategic Implications (2026–2032)
- 8.4 Bayer
- 8.4.1 Company Overview
- 8.4.2 Key Products & Segments
- 8.4.3 Financial Performance (2023–2025)
- 8.4.4 Business Strategy
- 8.4.5 SWOT Analysis
- 8.4.6 Strategic Implications (2026–2032)
- 8.5 Eli Lilly And Company
- 8.5.1 Company Overview
- 8.5.2 Key Products & Segments
- 8.5.3 Financial Performance (2023–2025)
- 8.5.4 Business Strategy
- 8.5.5 SWOT Analysis
- 8.5.6 Strategic Implications (2026–2032)
- 8.6 GlaxoSmithKline
- 8.6.1 Company Overview
- 8.6.2 Key Products & Segments
- 8.6.3 Financial Performance (2023–2025)
- 8.6.4 Business Strategy
- 8.6.5 SWOT Analysis
- 8.6.6 Strategic Implications (2026–2032)
- 8.7 Pfizer
- 8.7.1 Company Overview
- 8.7.2 Key Products & Segments
- 8.7.3 Financial Performance (2023–2025)
- 8.7.4 Business Strategy
- 8.7.5 SWOT Analysis
- 8.7.6 Strategic Implications (2026–2032)
- 8.8 Shionogi
- 8.8.1 Company Overview
- 8.8.2 Key Products & Segments
- 8.8.3 Financial Performance (2023–2025)
- 8.8.4 Business Strategy
- 8.8.5 SWOT Analysis
- 8.8.6 Strategic Implications (2026–2032)
- 8.9 Johnson & Johnson
- 8.9.1 Company Overview
- 8.9.2 Key Products & Segments
- 8.9.3 Financial Performance (2023–2025)
- 8.9.4 Business Strategy
- 8.9.5 SWOT Analysis
- 8.9.6 Strategic Implications (2026–2032)
- 8.10 Novartis AG
- 8.10.1 Company Overview
- 8.10.2 Key Products & Segments
- 8.10.3 Financial Performance (2023–2025)
- 8.10.4 Business Strategy
- 8.10.5 SWOT Analysis
- 8.10.6 Strategic Implications (2026–2032)
- 8.11 Merck & Co., Inc.
- 8.11.1 Company Overview
- 8.11.2 Key Products & Segments
- 8.11.3 Financial Performance (2023–2025)
- 8.11.4 Business Strategy
- 8.11.5 SWOT Analysis
- 8.11.6 Strategic Implications (2026–2032)
- 8.12 Allergan plc
- 8.12.1 Company Overview
- 8.12.2 Key Products & Segments
- 8.12.3 Financial Performance (2023–2025)
- 8.12.4 Business Strategy
- 8.12.5 SWOT Analysis
- 8.12.6 Strategic Implications (2026–2032)
- 8.13 Mylan N.V.
- 8.13.1 Company Overview
- 8.13.2 Key Products & Segments
- 8.13.3 Financial Performance (2023–2025)
- 8.13.4 Business Strategy
- 8.13.5 SWOT Analysis
- 8.13.6 Strategic Implications (2026–2032)
09Competitive Landscape
- 9.1 Competitive Landscape Overview
- 9.2 Competitive Intensity Assessment
- 9.3 Key Player Strategies & Positioning
- 9.4 Competitive Dynamics & Strategic Outlook
- 9.4.1 Emerging Competitive Threats
- 9.4.2 Consolidation vs. Fragmentation Outlook
- 9.4.3 Competitive Response Matrix
- 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
- 10.1 Threat of New Entrants
- 10.2 Bargaining Power of Buyers
- 10.3 Bargaining Power of Suppliers
- 10.4 Threat of Substitutes
- 10.5 Competitive Rivalry
11PESTLE Analysis
- 11.1 Political
- 11.2 Economic
- 11.3 Social and Demographic
- 11.4 Technological
- 11.5 Legal and Regulatory
- 11.6 Environmental
- 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
- 13.1 Future Trends & Outlook
- 13.1.1 Trend Summary and Commercial Maturity Assessment
- 13.1.2 Technology and Innovation Trends
- 13.1.3 Long-Term Market Outlook
- 13.1.4 Investment & M&A Activity Outlook
- 13.1.5 Overall Outlook Assessment
Frequently asked questions
How big is the global Premenstrual Syndrome Treatment market?
How fast is the Premenstrual Syndrome Treatment market expected to grow?
What does the Premenstrual Syndrome Treatment market cover?
What are the main segments of the Premenstrual Syndrome Treatment market by type?
Which applications drive demand in the Premenstrual Syndrome Treatment market?
Who are the key players in the Premenstrual Syndrome Treatment market?
Which regions and countries are covered for Premenstrual Syndrome Treatment?
What is driving growth in the Premenstrual Syndrome Treatment market?
Who should buy the Premenstrual Syndrome Treatment market report?
What license options are available for this report?
Research Methodology
All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.
Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.
Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.
Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.
CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.
All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.
On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.
Need a customized version?
Get country-, segment- or company-specific intelligence tailored to your exact requirements.
Request custom research →Request a free sample
Receive a sample of Global Premenstrual Syndrome Treatment Market Strategic Research Report before you buy.
Customize This Report
Describe your specific requirements and our analysts will scope and deliver a tailored version.
Request Invoice
We will email a proforma invoice within 24 hours. Report access is granted upon payment confirmation.
Navadhi Market Research · Healthcare & Medical Devices